NSD - This is one the problems with no accountability to shareholders.

As far as happening in your lifetime - perhaps this was a bad omen. The e-mail I got from IR had this as the Subject - Chairman's Update Oct. 3013 :)

Unfortunately they might have finally gotten a projection right! :(

EPA Status clarification. In the update they say they are currently completing tests, at the same time they say it is in the EPA's hands - which one is it?

Dr Shannon and our team at Queen's University are currently in the process of completing the EPA required validation runs. This is a time-consuming, complex process due to the high number of repeated runs required and the specific protocols prescribed by the EPA. This testing is now centered on showing bactericidal kill to the EPA disinfection standard using their specific methodologies.

While time consuming, the disinfection kill-levels required are well below AsepticSure's demonstrated capability. Thus, although we are confident of achieving EPA approval, the difficulty lies in putting a time frame on it - that is in the hands of the EPA. Once EPA approval is achieved, we will begin market entry into the US Sector.

Hard to believe that they designed a $100,000 machine to work with only one frequency. A $39.99 baby monitor uses 2. Dos anyone still think they don't need better/more experienced people working on this?

Very interesting. Nice to see that the technology is advancing and some encouraging news about Canadien interest. Still frustrating to hear that test results showing reduced HAI's are still way in the future - this has been talked about for years. All in all, encouraging to hear that things are moving forward.

Raising issues or trying to get clarifications is not bad mouthing in my book.

I never said all my shares were at 60 cents :), but not everyone can always afford to average down.

What logical connection is there between patent approval and EPA approval?

1. They are approving 2 completely different aspects of the technology

2. Patent approval had a progression of events, available to the public that we were able to follow, that allowed us to see the progress being made. EPA has been silent.

Right now there is just as good a chance that EPA comes out soon and denies the technology than the approve it. If they didn't have issues with it, they could have approved it a long time ago.

As far as the old argument of "selling and moving on" remember some of us have shares bought in the 60 cent range.

These are the same people who were so confident 2 years ago that this approval was basically a done deal. In May they thought it was weeks away - While we cannot predict with certainty, our expectation is that regulatory approval by the EPA will be forthcoming in the weeks following that meeting.


As far as registering for the show they had done that by June 2 when they assumed they were weeks away from approval, so that doesn't prove anything as to the likelihood of an approval before the show.

Unless you know of anything more that has transpired recently regarding this, I can't feel confident that it is coming anytime soon.

BenK - What is "your opinion" based on? We have heard nothing from the company regarding this in over 4 months. If it was that easy/sure, we would have had it done way before the shutdown. What makes you think we are any closer now than we were 4 months ago?


>> IMO there won't be any reason that we won't have EPA approval before year's end, if not sooner.

It is great news but without EPA approval we are still dead in the water.

http://www.medizoneint.com/asepticsure-hospital-disinfection-technology-receives-patent-protection/

AsepticSure Hospital Disinfection Technology Receives US Patent Protection

In a world-first, a new green technology capable of decontaminating infected hospital and health care rooms to the standard of > 6 log (>99.9999%) has received US patent protection.
San Francisco, California, October 8, 2013. Medizone International, Inc. (MZEI:OB, MZEI:QB) is pleased to announce that its WHO award-winning green infection control technology, AsepticSure® has been Granted a patent by the United States Patent and Trademark office. (US 61/223,219) titled “Healthcare Facility Disinfecting System”. The AsepticSure infection control system has repeatedly demonstrated 100% microbial kill rates when used to decontaminate hospital rooms of the causative agents of HAI (hospital acquired infections).

“With patent protection now established in the United States, Canada and Singapore and pending applications in process for the 37 member countries of the EU as well as Korea, Japan, China, India, Brazil and Mexico, our patent momentum is clearly gaining strength”, stated Edwin Marshall, Medizone’s CEO.

“This ruling by the US Examiner should also prove to be most favorable for us with other pending applications. As an example, the application for our government variant of AsepticSure (designed for building remediation following biological attack), was originally challenged by the Examiner, stating many of the same objections as originally stated for our Health Care application. Now that we've received a grant of the health care patent, the accepted approach to overcoming those same objections for the government variant is likely to be accepted.

In our opinion, it is clear that our patent strategy is working. Taken in combination with the fact that AsepticSure is the only green technology in the world capable of reliably decontaminating infected rooms to the standard of > 6 log (>99.9999%) bactericidal reduction while room content remains in place, there can be no doubt that we're building significant and sustainable long-term value into the company.”

In preparation for US market entry, which is currently anticipated during Q4, Medizone will showcase AsepticSure at the ISSA/ Interclean show to be held at the Las Vegas Convention Center November 19 – 21.

Ah yes - waterdog451 I remember him well. With the famous quote in December 2010

"Very, very soon, the PR’s will flow like warm honey - not from within MZEI but from every corner of the world. There is absolutely nothing that can hinder this; nothing that can derail this; and absolutely NOTHING that can stop it. The “setbacks” are all behind us now. It’s no longer a matter of time, but a matter of fact. "

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=57543943

Thanks. Is this "prior art" a new development that wasn’t part of the original rejection? If yes why did it only come up now?

Has anyone heard from the company what their response is to the Steris patent?

>>the bigger hurdle is the prior art referenced in both application rejections thus far...

Eli - what happened? I haven't been following the patent saga closely, but I thought the problem was overlapping claims within the Medizone application. BenK claimed his lawyer friend said this was no big deal.

Is this objection something new that the patent office just came up with?

I thought our patent lawyers did the initial investigation when we first filed and didn't see any previous patents that would cause us a problem?

Why did Canada not have the same issue - was the Steris patent not filed in Canada?



Lots of questions - we need Ed to address this in detail. This obviously has major ramifications

BenK - I think you might have to wait just a bit. While there was a lot of long-term promising information in this update, it also raised significant questions.

Funding continues to be an issue and is holding back progress - which is mind-boggling to me that they can't raise funds at decent valuation.

EPA approval still not forthcoming - asking for a meeting doesn't seem standard, so while they say they are confident in ultimate approval it is still very much up in the air.

Ditto for patents - Sounds like Medizone wants a meeting, but none has been scheduled as of yet.

>> Fasten your seat belts everybody...

Benk - I wonder why they didn't pr the FDA Approval? Also not to complain but this message would have been nice on Monday

I would be interested to know if the recent attention lead to a significant increase in people signing up for alerts etc..

If you would like to receive E-mail announcements of Medizone news when it breaks, there is a link located on the right hand side of the Medizone web site home page:

Thanks WIV - So Asepticsure should make this report obsolete.

Nice update! Is a meeting with Patent office typical before granting a patent?

WIV - Good to have you back on the board! What is your thoughts on the Frost and Sullivan projection of only $80 million revenue for the entire market in 3 years?

http://news.yahoo.com/hospitals-see-surge-superbug-fighting-063400543.html

The market niche is expected to grow from $30 million to $80 million in the next three years, according to Frost & Sullivan, a market research firm.

I seems rather obvious to me that the Marketwatch article on Monday and then Yahoo reposting it as a lead on Friday caused the volume. To me the biger question is who bought - traders in for a quick profit ( who will be gone once the voume dries up) or investors in for the long haul?

NSD - I usually agree with your posts, but to say nothing significance has happened lately is a stretch. Sales have commenced and the partnership with Wood Wyant is significant. I know it is only Canada, but it does mean something that the largest distributor of sanitation products was interested in Asepticsure.

I understand your frustration with management and share it but there has been movement.

As far as recent volume - I think it is mostly day-trader types and will dry up soon unless FDA/EPA/Patent announcements are made soon. Last I checked the Yahoo story had over 3,000 comments so someone is reading it.

Another Yahoo article. Unfortunately it profiles Xenex. The other disconcerting fact is that they expect the market to only reach $80 million dollars in the next 3 years. I sure hope they are wrong!

http://news.yahoo.com/hospitals-see-surge-superbug-fighting-063400543.html

The market niche is expected to grow from $30 million to $80 million in the next three years, according to Frost & Sullivan, a market research firm.

Eli - If these guys trust management so much why can't Medizone get more for their shares from these inside investors?

BenK - I think you've said several times that the people behind current management know more what is going on and they are confident etc..
If that is the case why were they only able to raise funds at .03?

From the 10Q:

During the three months ended March 31, 2013, we generated cash of $367,000 through the sale of 12,233,332 shares of common stock to 12 accredited investors at a price of $0.03 per share

Nice start to the morning :) Any comments if this volume is due to new investors or day traders?

ok, I'll take that - buying volume sounds good:) I was only looking at total volume.

Top story on my Yahoo also

Eli - increased volume?? Previous weeks average volume per day was 343,000. This weeks average volume was 345,000. Full credit for $180 a day increase?

Great - then I'll only be down 55 cents from my purchase after the Groundell fiasco.

More seriously - did you notice any great increase in volume due to the media exposure? What rational investor would invest in a company that hasn't had a shareholders meeting in close to 4 years, has no quarterly calls after "earnings" report etc.., in other words isn't acting like a company that cares about it's shareholders. All the reasons for the lack of the above can be debated, but in the end if you want to be treated like a normal succesful company you have to act like one.

Star - Last I heard from IR (several months ago) was that they weren't pursuing media coverage because they wanted to first do some major brand development and that was on hold until they got some major funding.

While I'm very excited to hear that mainstream media knows about Medizone, it seems amateurish for Medizone to have this as their lead on their web-site. This article was not about Medizone's success in treating HAIs, that was mentioned as a "by the way", and Asepticsure does not currently have a market-ready solution for bed bugs.

I know - some people are never happy :)

Exactly - Curious to know who made that contact.

Eli - Very nice!! That is one step away from the WSJ! I think this is the most prominent mention of Medizone in mainstream media that I can recall

Exactly the problem is much deeper - no one trusts that current manegement can get the job done. It's not just a couple of complainers on IHub that believe this, but seemingly all potential investors.

>> The issue we're facing is much deeper

BenK - Glad to hear you are feeling better.

What do attribute the "ridiculous" price to? Things are progressing, we have sales etc..
Still don't think this points to a lack on confidence in current management by potential investors? At some point they need to take responsibility for the share price. Even if they are 100% successful in all other areas of the company their ultimate responsibility as a public company is to increase shareholder value.

SALES! :)

For years we've been hearing from pro-management followers that the stock price won't move until we have sales. Well it seems that we've made significant strides in that area and yet the share price languishes. Seems to me that there is still a strong doubt in potential investors minds about current managements ability to turn this into a profitable company.

Anyone understand what is going to happen with C3? Do they now have overlapping distributors competing for clients, or are they replacing C3?

It is hard to believe, with the potential this company has, that we are down to 7 cents. It clearly indicates a lack of confidence in current management’s ability to bring this to fruition. Otherwise the risk/reward of this stock seems to make it a very strong buy. If investors who are aware of the company don't trust management, how can we expect institutional investors to ever invest in this company as long as the same management is running the show.

Karl - 20 cents/share sounds like a reasonable initial target

They have a $25m backlog, so it's not unreasonable to project $50m in sales this year. Net profit of 15% = $7.5m profit. A P/E of 30 for a growing company in a large new market gets you a market value of $225m = 18.75c/share.

Did he say why they needed an extension and couldn't get their response filed in a timely fashion?